These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31402101)

  • 1. Transfusion medicine: A research agenda for the coming years.
    Blumberg N; Cholette JM; Cahill C; Pietropaoli AP; Winters S; Phipps R; Noronha SA; Heal JM; Kirkley SA; Fountaine TJ; Henrichs K; Masel D; Refaai MA
    Transfus Apher Sci; 2019 Oct; 58(5):698-700. PubMed ID: 31402101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How do we forecast tomorrow's transfusion? - Next generation transfusion practices to improve recipient safety.
    Blumberg N; Heal JM
    Transfus Clin Biol; 2023 Feb; 30(1):31-34. PubMed ID: 36096445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninfectious transfusion-associated adverse events and their mitigation strategies.
    Goel R; Tobian AAR; Shaz BH
    Blood; 2019 Apr; 133(17):1831-1839. PubMed ID: 30808635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transfusion dilemma--weighing the known and newly proposed risks of blood transfusions against the uncertain benefits.
    Refaai MA; Blumberg N
    Best Pract Res Clin Anaesthesiol; 2013 Mar; 27(1):17-35. PubMed ID: 23590913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood product transfusions and reactions.
    Osterman JL; Arora S
    Emerg Med Clin North Am; 2014 Aug; 32(3):727-38. PubMed ID: 25060259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reflections on current status of blood transfusion transplant viral safety in UK/Europe and on novel strategies for enhancing donors/recipients healthcare in promising era of advanced cell therapy/regenerative medicine.
    Seghatchian J
    Transfus Apher Sci; 2019 Aug; 58(4):532-537. PubMed ID: 31248735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reasons for moving toward a patient-centric paradigm of clinical transfusion medicine practice.
    Vamvakas EC
    Transfusion; 2013 Apr; 53(4):888-901. PubMed ID: 22882177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Importance of haemovigilance and reports on transfusion reaction in blood component therapy].
    Grujić J; Gulan Z; Budakov Z
    Med Pregl; 2012; 65(1-2):50-3. PubMed ID: 22452240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion immunomodulation--the case for leukoreduced and (perhaps) washed transfusions.
    Lannan KL; Sahler J; Spinelli SL; Phipps RP; Blumberg N
    Blood Cells Mol Dis; 2013 Jan; 50(1):61-8. PubMed ID: 22981700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.
    Sahai T; Henrichs K; Refaai M; Heal JM; Kirkley SA; Schmidt AE; Mendler JH; Masel D; Liesveld J; Aquina C; Blumberg N
    Leuk Res; 2017 Nov; 62():1-3. PubMed ID: 28963906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of ABO-incompatible transfusion].
    Fujii Y
    Masui; 2011 Jan; 60(1):47-54. PubMed ID: 21348250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions.
    Dunbar NM; Katus MC; Freeman CM; Szczepiorkowski ZM
    Transfusion; 2015 Aug; 55(8):1882-8. PubMed ID: 25757728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serious hazards of transfusion - conference report: celebration of 20 years of UK haemovigilance.
    Bolton-Maggs PHB
    Transfus Med; 2017 Dec; 27(6):393-400. PubMed ID: 29282809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood component preferences of transfusion services supporting infant transfusions: a University HealthSystem Consortium benchmarking study.
    Fung MK; Roseff SD; Vermoch KL
    Transfusion; 2010 Sep; 50(9):1921-5. PubMed ID: 20456704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to minimize infection risk in blood banking and transfusion practice.
    Lindholm PF; Annen K; Ramsey G
    Infect Disord Drug Targets; 2011 Feb; 11(1):45-56. PubMed ID: 21303341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble antigens in plasma allow mismatched transfusion without hemolysis.
    Sikora J; Gregory J; George A; Clayton S; Zou B; Robinson M; Mukhtar F; Pelletier JP
    Transfusion; 2018 Apr; 58(4):1006-1011. PubMed ID: 29392728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The best blood product and its best use for each patient: An evolving role for hemovigilance?
    Tiberghien P
    Transfus Clin Biol; 2019 Sep; 26(3):188-191. PubMed ID: 31178340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion errors - can they be eliminated?
    Bolton-Maggs PHB; Watt A
    Br J Haematol; 2020 Apr; 189(1):9-20. PubMed ID: 31792932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABO and platelet transfusion revisited.
    Heal JM; Rowe JM; Blumberg N
    Ann Hematol; 1993 Jun; 66(6):309-14. PubMed ID: 8318561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.